 Barclays PLC raised its position in Five Prime Therapeutics Inc NASDAQ:FPRX by 45.7 during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission SEC. The firm owned 45,533 shares of the biotechnology companys stock after purchasing an additional 14,287 shares during the quarter. Barclays PLC owned 0.13 of Five ... 